Cell & gene therapy

Research Field Cell & gene therapy

Now For the High-Hanging Fruit

| Miguel Forte

We should be thrilled with the success of the approved CD-19 CAR-T therapies. But the field is still young, and we are only scratching the surface.

Outside the Lab Professional development

Revolutionizing Medicine – While Learning “Novartian”

| James Strachan

Sitting Down With... Bruce Levine, Professor in Cancer Gene Therapy, Perelman School of Medicine, University of Pennsylvania.

Research Field Neuroscience

Building up to a breakthrough

| Jonathan James

We sat down with David Eidelberg shortly after the publication of his group’s most recent paper in Science Translational Medicine.

Research Field Cell & gene therapy

FDA Quackdown

| James Strachan

Regulators step in to stop stem cell clinics from marketing unproven therapies.

Research Field Cell & gene therapy

Fresher and CRISPR

The promise of genome editing is tempered for genetically heterogeneous diseases – introducing a new approach for rhodopsin-dependent retinitis pigmentosa.

Research Field Cell & gene therapy

The Best Treatment

| Ruth Steer

Is gene therapy the answer to an untreatable form of macular degeneration?

Research Field Cell & gene therapy

The Secret is the Secretions

| Nicolas Sohl

Stem cells hold great promise, but is it the cells we really need?

Research Field Cell & gene therapy

Pulling Back the Curtain: Combinatorial Screening

| Shahzad Ali

What are the realities of translating exciting cell and gene therapy research into something more tangible?

Research Field Imaging

Image of the Month

| Charlotte Barker

Stem cells with a seasonal theme.

Research Field Drug discovery

Believe in RNAi

| Geert Cauwenbergh

The gates for gene and cell therapies are open, and RNAi technology could be a serious contender

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register